International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Comparative Evaluation of High-Flow Nasal Cannula and Non-Invasive Ventilation in Patients with Type II Respiratory Failure: A Randomized Controlled Study

Article Information

Volume / Issue7 / 1 (January-March 2026)
Pages13-23
AccessOpen Access

Publication Timeline

  • Received26 October 2025
  • Accepted27 November 2025

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Background: Type II respiratory failure remains a significant cause of morbidity and mortality in critically ill patients. While non-invasive ventilation (NIV) is the established standard of care, high-flow nasal cannula (HFNC) has emerged as a promising alternative respiratory support modality.
Objective: To compare the clinical efficacy, safety, and patient tolerance of HFNC versus NIV in patients with acute type II respiratory failure.
Methods: This prospective randomized controlled trial was conducted over 18 months in a tertiary care respiratory intensive care unit. Eighty patients with acute type II respiratory failure were randomly allocated to receive either HFNC (n=40) or NIV (n=40). Primary outcome measures included improvement in arterial blood gas parameters (pH, PaCO₂, PaO₂), respiratory rate, heart rate, and treatment failure rates. Secondary outcomes included patient comfort scores, complications, duration of respiratory support, intensive care unit length of stay, and in-hospital mortality.
Results: Both groups demonstrated significant improvement in arterial blood gas parameters at 1, 6, 12, and 24 hours. The NIV group showed faster correction of hypercapnia and respiratory acidosis at 1 hour (mean PaCO₂: 52.3±6.8 vs 58.7±7.2 mmHg, p<0.001). However, by 24 hours, differences in pH and PaCO₂ were not statistically significant between groups. HFNC demonstrated superior patient comfort scores (8.2±1.1 vs 5.6±1.4, p<0.001) and significantly lower rates of skin breakdown (2.5% vs 22.5%, p=0.006). Treatment failure rates were comparable (HFNC: 12.5% vs NIV: 15.0%, p=0.74). No significant differences were observed in ICU length of stay or mortality rates.
Conclusion: HFNC represents an effective and well-tolerated alternative to NIV in managing acute type II respiratory failure, particularly in patients who may not tolerate NIV. While NIV provides faster initial correction of hypercapnia, HFNC offers comparable efficacy with superior comfort and fewer interface-related complications.
 

References

  1. Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J Suppl. 2003;47:3s-14s. [Google Scholar][Crossref]
  2. Carlucci A, Richard JC, Wysocki M, Lepage E, Brochard L. Noninvasive versus conventional mechanical ventilation: an epidemiologic survey. Am J Respir Crit Care Med. 2001;163(4):874-880. [Google Scholar][Crossref]
  3. Lightowler JV, Wedzicha JA, Elliott MW, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta -analysis. BMJ. 2003;326(7382):185. [Google Scholar][Crossref]
  4. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med. 2001;163(2):540-577. [Google Scholar][Crossref]
  5. Scala R, Naldi M. Ventilators for noninvasive ventilation to treat acute respiratory failure. Respir Care. 2008;53(8):1054-1080. [Google Scholar][Crossref]
  6. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333(13):817-822. [Google Scholar][Crossref]
  7. Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet. 2000;355(9219):1931-1935. [Google Scholar][Crossref]
  8. Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med. 2004;32(12):2516-2523. [Google Scholar][Crossref]
  9. Ram FS, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2004;(3):CD004104. [Google Scholar][Crossref]
  10. Osadnik CR, Tee VS, Carson-Chahhoud KV, et al. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7(7):CD004104. [Google Scholar][Crossref]
  11. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2023 Report. Available from: www.goldcopd.org. [Google Scholar][Crossref]
  12. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. [Google Scholar][Crossref]
  13. Carlucci A, Delmastro M, Rubini F, Fracchia C, Nava S. Changes in the practice of non-invasive ventilation in treating COPD patients over 8 years. Intensive Care Med. 2003;29(3):419-425. [Google Scholar][Crossref]
  14. Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet. 2009;374(9685):250-259. [Google Scholar][Crossref]
  15. Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103(10):1400-1405. [Google Scholar][Crossref]
  16. Möller W, Feng S, Domanski U, et al. Nasal high flow reduces dead space. J Appl Physiol. 2017;122(1):191-197. [Google Scholar][Crossref]
  17. Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care. 2013;58(10):1621-1624. [Google Scholar][Crossref]
  18. Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207-1215. International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
  19. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185-2196. [Google Scholar][Crossref]
  20. Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019;45(5):563-572. [Google Scholar][Crossref]
  21. Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J. 2018;12(6):2046-2056. [Google Scholar][Crossref]
  22. Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respir Res. 2017;18(1):51. [Google Scholar][Crossref]
  23. Bräunlich J, Köhler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077-1085. [Google Scholar][Crossref]
  24. Hernández G, Vaquero C, González P, et al. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA. 2016;315(13):1354-1361. [Google Scholar][Crossref]
  25. Maggiore SM, Battilana M, Serano L, Petrini F. Ventilatory support after extubation in critically ill patients. Lancet Respir Med. 2018;6(12):948-962. [Google Scholar][Crossref]
  26. Hess DR. Noninvasive ventilation for acute respiratory failure. Respir Care. 2013;58(6):950-972. [Google Scholar][Crossref]
  27. Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61(4):529-541. [Google Scholar][Crossref]
  28. Roca O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respir Care. 2010;55(4):408-413. [Google Scholar][Crossref]
  29. Demoule A, Girou E, Richard JC, Taille S, Brochard L. Benefits and risks of success or failure of noninvasive ventilation. Intensive Care Med. 2006;32(11):1756-1765. [Google Scholar][Crossref]
  30. Mas A, Masip J. Noninvasive ventilation in acute respiratory failure. Int J Chron Obstruct Pulmon Dis. 2014;9:837-852. [Google Scholar][Crossref]
  31. Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009;103(6):886-890. [Google Scholar][Crossref]
  32. Möller W, Celik G, Feng S, et al. Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol. 2015;118(12):1525-1532. [Google Scholar][Crossref]
  33. Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis. 2008;5(2):81-86. [Google Scholar][Crossref]
  34. Appendini L, Patessio A, Zanaboni S, et al. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;149(5):1069-1076. [Google Scholar][Crossref]
  35. Girault C, Richard JC, Chevron V, et al. Comparative physiologic effects of noninvasive assist-control and pressure support ventilation in acute hypercapnic respiratory failure. Chest. 1997;111(6):1639-1648. [Google Scholar][Crossref]
  36. Doshi P, Whittle JS, Bublewicz M, et al. High-velocity nasal insufflation in the treatment of respiratory failure: a randomized clinical trial. Ann Emerg Med. 2018;72(1):73-83. [Google Scholar][Crossref]
  37. Cortegiani A, Crimi C, Sanfilippo F, et al. High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care. 2019;50:250-256. [Google Scholar][Crossref]
  38. Gregoretti C, Confalonieri M, Navalesi P, et al. Evaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study. Intensive Care Med. 2002;28(3):278-284. [Google Scholar][Crossref]
  39. Carlucci A, Richard JC, Wysocki M, Lepage E, Brochard L. Noninvasive versus conventional mechanical ventilation: an epidemiologic survey. Am J Respir Crit Care Med. 2001;163(4):874-880. [Google Scholar][Crossref]
  40. Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications. Chest. 2015;148(1):253-261. [Google Scholar][Crossref]
  41. Yamaguti WP, Moderno EV, Yamashita SY, et al. Treatment-related risk factors for development of skin breakdown in subjects with acute respiratory failure undergoing noninvasive ventilation or CPAP. Respir Care. 2014;59(10):1530-1536. [Google Scholar][Crossref]
  42. Weng MH. The effect of protective treatment in reducing pressure ulcers for non-invasive ventilation patients. Intensive Crit Care Nurs. 2008;24(5):295-299. [Google Scholar][Crossref]
  43. Roca O, Pérez-Terán P, Masclans JR, et al. Patients with New York Heart Association class III heart failure may benefit more from high flow nasal cannula than from non-invasive positive pressure ventilation. Crit Care. 2013;17(2):R46. [Google Scholar][Crossref]
  44. Gregoretti C, Pelosi P, Gianni R, et al. Comparison between a new and conventional helmet for noninvasive ventilation: a physiological and comfort study. Intensive Care Med. 2003;29(10):1788-1794. [Google Scholar][Crossref]
  45. Rittayamai N, Tscheikuna J, Rujiwit P. High-flow nasal cannula versus conventional oxygen therapy after endotracheal extubation: a randomized crossover physiologic study. Respir Care. 2014;59(4):485-490. [Google Scholar][Crossref]
  46. Keenan SP, Sinuff T, Burns KE, et al. Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting. CMAJ. 2011;183(3):E195-E214. [Google Scholar][Crossref]
  47. Fernandez R, Subira C, Frutos-Vivar F, et al. High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial. Ann Intensive Care. 2017;7(1):47. [Google Scholar][Crossref]
  48. Esteban A, Anzueto A, Frutos F, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA. 2002;287(3):345-355. [Google Scholar][Crossref]
  49. Stéphan F, Barrucand B, Petit P, et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA. 2015;313(23):2331-2339. [Google Scholar][Crossref]
  50. Lemiale V, Mokart D, Mayaux J, et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA. 2015;314(16):1711-1719. [Google Scholar][Crossref]
  51. Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe International Journal of Medical and All Body Health Research www.allmedicaljournal.com stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698-705. [Google Scholar][Crossref]
  52. Carrillo A, Gonzalez-Diaz G, Ferrer M, et al. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med. 2012;38(3):458-466. [Google Scholar][Crossref]
  53. Thille AW, Contou D, Fragnoli C, Córdoba-Izquierdo A, Boissier F, Brun-Buisson C. Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors. Crit Care. 2013;17(6):R269. [Google Scholar][Crossref]
  54. Rello J, Pérez M, Roca O, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care. 2012;27(5):434-439. [Google Scholar][Crossref]
  55. Mauri T, Alban L, Turrini C, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med. 2017;43(10):1453-1463. [Google Scholar][Crossref]

How to Cite

Solanki, S., Redhu, S., Anash, M., Sahay, S., & Saini, R. (2026). Comparative Evaluation of High-Flow Nasal Cannula and Non-Invasive Ventilation in Patients with Type II Respiratory Failure: A Randomized Controlled Study. International Journal of Medical and All Body Health Research, 7(1), 13-23. https://doi.org/10.54660/IJMBHR.2026.7.1.13-23

Solanki, Sagar, et al. "Comparative Evaluation of High-Flow Nasal Cannula and Non-Invasive Ventilation in Patients with Type II Respiratory Failure: A Randomized Controlled Study." International Journal of Medical and All Body Health Research, vol. 7, no. 1, 2026, pp. 13-23. https://doi.org/10.54660/IJMBHR.2026.7.1.13-23.

Solanki, S., Redhu, S., Anash, M., Sahay, S. and Saini, R. (2026) 'Comparative Evaluation of High-Flow Nasal Cannula and Non-Invasive Ventilation in Patients with Type II Respiratory Failure: A Randomized Controlled Study', International Journal of Medical and All Body Health Research, 7(1), pp. 13-23. doi: 10.54660/IJMBHR.2026.7.1.13-23.

Solanki S, Redhu S, Anash M, Sahay S, Saini R. Comparative Evaluation of High-Flow Nasal Cannula and Non-Invasive Ventilation in Patients with Type II Respiratory Failure: A Randomized Controlled Study. International Journal of Medical and All Body Health Research. 2026;7(1):13-23. doi:10.54660/IJMBHR.2026.7.1.13-23

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.